Financial HealthAs of June 30, 2025, SBC Medical had cash and equivalents of $152.7M and total debt of $7.1M, indicating strong financial health and no anticipated need for additional capital.
International ExpansionSBC Medical is actively evaluating opportunities to enter the US through either a strategic partnership or acquisition, expected by year-end 2026.
Market ValuationShares currently trade at an EV/revenue multiple of 1.0x the 2026 estimate, below the peer average of 2.0x, excluding SBC, which suggests compelling valuation.